Lista de obras -

A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.

artículo científico publicado en 2015

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

artículo científico publicado en 2017

A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.

artículo científico publicado en 2016

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.

artículo científico

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

artículo científico publicado en 2002

An evaluation of enasidenib for the treatment of acute myeloid leukemia

artículo científico publicado en 2019

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program

scientific article published on 14 July 2011

CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

artículo científico publicado en 2011

CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias

artículo científico publicado en 2004

Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.

artículo científico publicado en 2014

Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients

scientific article published on 01 August 2004

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

artículo científico publicado en 2017

Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia

scientific article published on 01 April 2002

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2006

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

artículo científico publicado en 2015

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

artículo científico publicado en 2018

Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients

scientific article published on 01 January 2003

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2008

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

artículo científico publicado en 2010

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

artículo científico publicado en 2015

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage

artículo científico publicado en 2015

Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes

scientific article published on 17 November 2007

Extensive toxic epidermal necrolysis following brentuximab vedotin administration

article

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

artículo científico publicado en 2017

Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23+/MLL+ translocation in leukaemia

scientific article published on 01 June 2003

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2019

Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes

scientific article published on 21 September 2007

High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma

artículo científico publicado en 2014

Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient

scientific article published on 20 April 2007

Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia

artículo científico publicado en 2013

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

scientific article published on 21 February 2018

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

artículo científico publicado en 2018

MRD in AML: The Role of New Techniques

scientific article published on 23 July 2019

Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia

artículo científico publicado en 2018

Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia

artículo científico publicado en 2014

Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party.

artículo científico publicado en 2018

Monitoring of minimal residual disease in acute myeloid leukemia

artículo científico publicado en 2009

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

scientific article published on 01 May 2007

Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

artículo científico publicado en 2003

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.

artículo científico publicado en 2014

Opioids in pain management of blood-related malignancies.

artículo científico publicado en 2006

P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.

artículo científico publicado en 2003

Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

scientific article published on 01 April 2002

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

artículo científico publicado en 2017

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

artículo científico publicado en 2016

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

artículo científico publicado en 2007

Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.

artículo científico publicado en 2014

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

artículo científico publicado en 2010

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

artículo científico publicado en 2015

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia

artículo científico publicado en 2005

The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.

artículo científico publicado en 2010

Thoracic cord compression caused by epidural extramedullary hematopoiesis during erythroid-stimulating agent therapy in two patients with myelodysplastic syndromes

artículo científico publicado en 2013

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

artículo científico publicado en 2008

Treatment of Low-Blast Count AML using Hypomethylating Agents

artículo científico publicado en 2017

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

artículo científico publicado en 2009

Lista de obras de

A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

An evaluation of enasidenib for the treatment of acute myeloid leukemia

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program

CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias

Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.

Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage

Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes

Extensive toxic epidermal necrolysis following brentuximab vedotin administration

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23+/MLL+ translocation in leukaemia

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes

High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma

Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient

Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

MRD in AML: The Role of New Techniques

Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia

Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia

Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party.

Monitoring of minimal residual disease in acute myeloid leukemia

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.

Opioids in pain management of blood-related malignancies.

P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.

Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia

The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.

Thoracic cord compression caused by epidural extramedullary hematopoiesis during erythroid-stimulating agent therapy in two patients with myelodysplastic syndromes

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

Treatment of Low-Blast Count AML using Hypomethylating Agents

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.